BDX 财务： Becton Dickinson and Co AI 分析

主页

股票

BDX

财务数据

BDX 财务

Becton Dickinson and Co

$155.32

0.52%

$0.8

收盘价：Apr 06, 16:00:00 GMT-4

$155.9

0.37%

$0.58

盘后：Apr 06, 20:00:00 GMT-4

概述预测收益股息财务数据

关键数据

前收盘价

$154.51

开盘价

$153.79

当日区间

$152.98 - $155.93

52周范围

$127.53 - $187.35

交易量

1.8M

平均成交量

2.3M

股息收益率

2.51%

每股收益（TTM）

6.12

市值

$44.3B

什么是 BDX？

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.

功能特性

资源

市场

收入

资产负债表

现金流量

年度

季度性

BDX 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021
营收	21,924	21,840	20,178	19,372	18,870	19,131
营收同比增长 (YoY)	6%	8%	4%	3%	-1%	19%
营收成本	11,747	11,817	11,015	10,549	10,267	10,444
毛利润	10,177	10,023	9,163	8,823	8,603	8,687
销售、一般及管理费用	5,352	5,278	4,857	4,719	4,709	4,719
研发	1,227	1,235	1,190	1,237	1,256	1,279
营业费用	6,593	6,514	6,257	6,000	5,983	6,360
其他非经营性收入 (费用)	-102	-57	-11	-66	-17	-7
税前利润	1,969	1,881	2,005	1,662	1,783	1,692
所得税费用	212	203	300	132	148	88
净利润	1,757	1,678	1,705	1,424	1,689	2,002
净利润增长	1%	-2%	20%	-16%	-16%	161%
稀释后流通股数	285.84	288.5	291	288.39	287	292
股份同比变动 (YoY)	-2%	-1%	1%	0%	-2%	4%
每股收益 (摊薄)	6.14	5.81	5.85	4.93	5.88	6.85
每股收益增长率	2%	-1%	19%	-16%	-14%	153%
自由现金流	2,631	2,670	3,073	2,115	1,661	3,452
每股自由现金流	--	--	--	--	--	--
毛利率	46.41%	45.89%	45.41%	45.54%	45.59%	45.4%
营业利润率	16.34%	16.06%	14.4%	14.57%	13.88%	12.16%
净利率	8.01%	7.68%	8.44%	7.35%	8.95%	10.46%
自由现金流利润率	12%	12.22%	15.22%	10.91%	8.8%	18.04%
EBITDA	6,053	5,971	5,192	5,111	4,849	4,557
EBITDA 利润率	27.6%	27.33%	25.73%	26.38%	25.69%	23.81%
EBITDA 中的折旧与摊销	2,469	2,462	2,286	2,288	2,229	2,230
EBIT	3,584	3,509	2,906	2,823	2,620	2,327
EBIT 利润率	16.34%	16.06%	14.4%	14.57%	13.88%	12.16%
有效税率	10.76%	10.79%	14.96%	7.94%	8.3%	5.2%

Follow-Up Questions

Becton Dickinson and Co 的关键财务报表是什么？



根据最新的财务报表（Form-10K），Becton Dickinson and Co 的总资产为 $55,325，净利润为 $1,678

BDX 的关键财务比率是什么？



Becton Dickinson and Co 的流动比率是 1.84，净利 margin 为 7.68，每股销售为 $75.69。

Becton Dickinson and Co 的收入按细分市场或地理位置如何划分？



Becton Dickinson and Co 最大收入来源是 Medication Delivery Solutions，在最近的收益报告中收入为 4,575,000,000。就地区而言， United States 是 Becton Dickinson and Co 的主要市场，收入为 12,790,000,000。

Becton Dickinson and Co 是否盈利？



是的，根据最新的财务报表，Becton Dickinson and Co 的净利润为 $1,678

Becton Dickinson and Co 有负债吗？



是的，Becton Dickinson and Co 的负债为 29,935

Becton Dickinson and Co 的流通股有多少？



Becton Dickinson and Co 的总流通股为 285.4

Becton Dickinson and Co (BDX) 财务

BDX 股价走势图